APA (7th ed.) Citation

Palich, R., Ursenbach, A., Hall, N., Becker, A., Allavena, C., Robineau, O., & Hocqueloux, L. (2026). Archived M184V/I Mutation and Risk of Virological Failure After Switching to Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate: A National Observational Study (Dat'AIDS Cohort). Open Forum Infectious Diseases, 13(7), 1. https://doi.org/10.1093/ofid/ofag399

Chicago Style (17th ed.) Citation

Palich, Romain, Axel Ursenbach, Nolwenn Hall, Agathe Becker, Clotilde Allavena, Olivier Robineau, and Laurent Hocqueloux. "Archived M184V/I Mutation and Risk of Virological Failure After Switching to Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate: A National Observational Study (Dat'AIDS Cohort)." Open Forum Infectious Diseases 13, no. 7 (2026): 1. https://doi.org/10.1093/ofid/ofag399.

MLA (9th ed.) Citation

Palich, Romain, et al. "Archived M184V/I Mutation and Risk of Virological Failure After Switching to Doravirine, Lamivudine, Tenofovir Disoproxil Fumarate: A National Observational Study (Dat'AIDS Cohort)." Open Forum Infectious Diseases, vol. 13, no. 7, 2026, p. 1, https://doi.org/10.1093/ofid/ofag399.